Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jul 25;11:3371–3383. doi: 10.2147/IJN.S108636

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 Fan et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Effect of O-CdTe QDs on cell quantity and autophagy was partially recovered by rapamycin.

Notes: (A) Rapamycin (1 ng/mL) reduced the toxicity of O-CdTe QDs at 8 hours. Toxicity was determined by colony-forming units (CFU). The results are expressed as mean ± standard deviation, n=3. *P<0.05. (B) Rapamycin partially recovered the transformation from GFP-Atg8 to GFP, which was inhibited by O-CdTe QDs at 16 hours. Intracellular GFP-Atg8 and GFP were measured using antibodies to GFP. (C) Quantification of (B). The ratio of free GFP/GFP-Atg8 in each group was calculated. The results are expressed as mean ± standard deviation, n=3. **P<0.01.

Abbreviations: CdTe QDs, cadmium telluride quantum dots; O-CdTe, orange-emitting CdTe; Rap, rapamycin.